HCA Healthcare, Inc.
HCALast close · Oct 16, 2026458.84−9.66 (−2.06%)
Market cap$99.3B
Key indicators
Revenue76.4B+6.7% on a year earlier
46.7B
51.3B
51.5B
58.8B
60.2B
65.0B
70.6B
75.6B
76.4B
78.5B
81.5B
85.3B
Fiscal year
FY201818
FY201919
FY202020
FY202121
FY202222
FY202323
FY202424
FY202525
TTMTTM
FY2026E26E
FY2027E27E
FY2028E28E
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | FY2026E | FY2027E | FY2028E |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||||||
| 46.7B | 51.3B+10.0% | 51.5B+0.4% | 58.8B+14.0% | 60.2B+2.5% | 65.0B+7.9% | 70.6B+8.7% | 75.6B+7.1% | 76.4B+6.7% | 78.5B | 81.5B | 85.3B | |
| — | 10.0% | 0.4% | 14.0% | 2.5% | 7.9% | 8.7% | 7.1% | 6.7% | 3.8% | 3.9% | 4.6% | |
| $10.66 | $10.07−5.5% | $10.93+8.5% | $21.16+93.6% | $19.15−9.5% | $18.97−0.9% | $22.00+16.0% | $28.33+28.8% | $29.03+29.1% | $29.50 | $32.11 | $35.33 | |
| Profitability | ||||||||||||
| 8.1% | 6.8%−1.3 pt | 7.3%+0.5 pt | 11.8%+4.6 pt | 9.4%−2.5 pt | 8.1%−1.3 pt | 8.2%+0.1 pt | 9.0%+0.8 pt | 8.9%+0.8 pt | · | · | · | |
| -76.5% | -124.8%−48.3 pt | 656.3%+781.1 pt | -745.6%−1401.8 pt | -203.9%+541.6 pt | -295.5%−91.6 pt | -230.5%+65.0 pt | -112.6%+117.9 pt | — | · | · | · | |
| Cash | ||||||||||||
| 3.2B | 3.4B+8.0% | 6.4B+85.7% | 5.4B−15.9% | 4.1B−23.3% | 4.7B+13.6% | 5.6B+20.3% | 7.7B+36.4% | 7.9B+60.2% | · | · | · | |
| 6.8% | 6.7%−0.1 pt | 12.4%+5.7 pt | 9.2%−3.3 pt | 6.9%−2.3 pt | 7.2%+0.4 pt | 8.0%+0.8 pt | 10.2%+2.2 pt | 10.4%+3.5 pt | · | · | · | |
| 487.0M | 550.0M+12.9% | 153.0M−72.2% | 624.0M+307.8% | 653.0M+4.6% | 661.0M+1.2% | 690.0M+4.4% | 679.0M−1.6% | — | · | · | · | |
| Balance sheet | ||||||||||||
| -6.63x | -12.01x−5.38x | 54.20x+66.21x | -37.06x−91.26x | -13.76x+23.30x | -22.32x−8.55x | -17.22x+5.10x | -7.71x+9.51x | -7.62x+5.05x | · | · | · | |
| 355.30M | 348.23M−2.0% | 343.61M−1.3% | 328.75M−4.3% | 294.67M−10.4% | 276.41M−6.2% | 261.81M−5.3% | 239.50M−8.5% | 226.65M−9.1% | · | · | · | |
E = analyst consensus (revenue and EPS only). TTM = the twelve months to Mar 31, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.